Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial

OBJECTIVES: The risks and benefits of initiating antiretroviral treatment (ART) at high CD4 cell counts have not been reliably quantified. The Strategic Timing of AntiRetroviral Treatment (START) study is a randomised international clinical trial that compares immediate with deferred initiation of A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:HIV Med
Main Authors: Sharma, S, Babiker, AG, Emery, S, Gordin, FM, Lundgren, JD, Neaton, JN, Bakowska, E, Schechter, M, Wiselka, MJ, Wolff, MJ
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4341937/
https://ncbi.nlm.nih.gov/pubmed/25711321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12231
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki